Last Updated on November 16, 2024 by The Health Master
DCGI: The Need for Interdisciplinary Approach
Dr. Rajiv Singh Raghuvanshi, the Drug Controller General of India (DCGI), recently emphasized the importance of an interdisciplinary approach in pharmaceutical education.
Speaking at Panjab University (PU), he highlighted the rapid growth of startups in various sectors, contrasting it with the slower pace of innovation in the pharmaceutical industry.
He stressed the importance of research and development to bridge this gap.
India’s Growing Global Footprint
As the head of the Central Drugs Standard Control Organisation (CDSCO), Dr. Raghuvanshi, DCGI has played a key role in India’s emergence as a global pharmaceutical powerhouse.
The country now supplies over 25% of the UK’s generic medicines.
The Future Lies in Interdisciplinary Innovation
In his lecture, Dr. Raghuvanshi delved into the latest trends and challenges in the pharmaceutical and medical device sectors.
He encouraged students to explore interdisciplinary fields like biotechnology, chemical engineering, and advanced technology to drive innovation.
Shifting Focus to Value-Based Manufacturing
To achieve the ambitious goal of reaching a trade value of $130 billion by 2030, Dr. Raghuvanshi called for a shift from volume-based to value-based manufacturing.
He stressed the importance of innovation and research in achieving this target.
A Noble Profession
Panjab University’s Vice-Chancellor, Prof. Renu Vig, also emphasized the significance of pharmacy as a noble profession that combines science, service, and innovation.
Key Takeaways:
- Interdisciplinary approach: A key driver of innovation in pharmaceuticals.
- Research and development: Essential for staying ahead in the industry.
- Value-based manufacturing: A shift from volume-based production.
- Global impact: India’s growing role in the global pharmaceutical market.
By focusing on these areas, India can strengthen its position as a global pharmaceutical hub.
-
What is the importance of interdisciplinary approach in pharmaceuticals?
An interdisciplinary approach can lead to groundbreaking innovations and solutions to complex healthcare challenges.
-
What are the key challenges facing the Indian pharmaceutical industry?
Some of the key challenges include increasing competition, regulatory hurdles, and the need for continuous innovation.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
DCGI and Cosmetics Industry to meet on Regulatory issues
DCGI granted approval for these Eye Drops
Streamlining Indian Pharmaceutical Regulatory System: DCGI
DCGI announces Stringent Measures and Digital Transformation Plans
DCGI approval granted for this new Antibiotic Drug Combination
DCGI and Cosmetics Industry to meet on Regulatory issues
Significance of Granules Manufacturing in the Pharmaceutical Industry
4th International Conference on Pharmaceutical and Healthcare: Lloyd
USFDA approval granted for Medical Device for heart condition
Drug recall: Ascorbic Acid Injection recalled due to this reason
Recommendations for New Rules for Nutraceuticals: FSSAI
India needs to boost Vaccine Manufacturing and Research
Anti dumping investigation on Aniline imports from China
USFDA concludes inspection at Granules India with zero observations
Delhi High Court grants Injunction in ‘KIND’ Trademark battle
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
